Total trials
95
Active
15
Phase 3
7
Total enrollment
10,464
Pipeline matrix
Showing 9 of 9 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Normal saline | — | — | — | — | — | 3 | |
| Tranexamic Acid | — | — | — | — | — | 2 | |
| Dinalbuphine Sebacate | — | — | — | — | — | 1 | |
| melatonin | — | — | — | — | — | 1 | |
| Benfotiamine | — | — | — | — | — | 1 | |
| Vitamin B1-6-12 | — | — | — | — | — | 1 | |
| Paracetamol | — | — | — | — | 2 | ||
| Mirogabalin | — | — | — | — | — | 1 | |
| Pregabalin | — | — | — | — | — | 1 |
Next readouts
- 2025-05-31
- 2025-11-06
- 2026-06
- 2026-09
- 2027-06-30
Top conditions
- Osteoarthritis, Knee7
- Knee Osteoarthritis6
- Postoperative Pain5
- COPD4
- Osteoarthritis4
- Total Knee Arthroplasty4
- Asthma3
- Pain, Postoperative3
Frequently asked questions about Thammasat University
- How many clinical trials does Thammasat University have on ClinicalTrials.gov?
- Thammasat University is listed as the lead sponsor on 95 clinical trials in ClinicalTrials.gov, 15 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Thammasat University's trials are in Phase 3?
- 7 of Thammasat University's trials are in Phase 3, spread across 9 active drug programs.
- What therapeutic areas does Thammasat University focus on?
- Thammasat University's most-studied conditions on ClinicalTrials.gov are Osteoarthritis, Knee, Knee Osteoarthritis, Postoperative Pain, COPD, Osteoarthritis.
- When are Thammasat University's next clinical trial readouts?
- Thammasat University has 5 upcoming primary-completion readouts tracked here; the soonest is “Comparing Efficiency of Mirogabalin and Pregabalin in Primary TKA”, expected around 2025-05-31.